(Q63812980)

English

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Randomized, Double-Blind, Parallel, Placebo-Controlled, Phase 4, Multicenter Study to Assess Efficacy and Safety of VESIcare® (Solifenacin Succinate) to Improve Urinary Continence of Subjects After Robotic Assisted Radical Prostatectomy (English)

0 references

0 references

0 references

2 August 2011

0 references

end time

21 October 2013

0 references

number of participants

640

0 references

clinical trial phase

phase IV clinical trial

0 references

research site

University of California, San Diego

0 references

University of Florida

0 references

Northwestern University

0 references

Lahey Clinic

0 references

Cleveland Clinic

0 references

Oregon Health & Science University

0 references

Virginia Mason Medical Center

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01371994

0 references

(Q63812980)

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)